Pediatric Laboratory Reference Range Guidelines

General Principles

• Laboratories must employ age‑specific, analyzer‑specific, and reagent‑specific reference intervals for pediatric blood tests; using adult ranges misclassifies approximately 30 % of healthy children as abnormal. 1, 2, 3
• The concept of developmental hemostasis recognizes that physiological blood‑parameter values change markedly from the neonatal period through adolescence, necessitating age‑appropriate interpretation. 4
• Standardized pediatric age groups (neonates, 1 month–1 year, 1–5 years, 6–10 years, 11–16 years) correspond to statistically distinct physiological states and should be used when selecting reference ranges. 1, 2, 3
• Reference intervals must be derived with the identical analyzer and reagent system used in the reporting laboratory; mismatched systems produce significant systematic bias. 1, 2, 5

Hematology Reference Intervals

Infants (1 month – 1 year)

• Current reference intervals for 1‑year‑old children show no significant sex differences, allowing combined male/female ranges; however, further research is required to refine age‑specific changes within this rapid developmental window. 2, 6

Children (1 – 5 years)

• Applying adult activated partial thromboplastin time (APTT) reference ranges to 1‑5‑year‑olds incorrectly classifies ~30 % of healthy children as abnormal; pediatric‑specific APTT ranges are essential. 4

Adolescents (11 – 16 years)

• Sex‑specific differences become prominent in the 12‑17 year age group for delta‑He, immature reticulocyte fraction (IRF), and the percentage of hypochromic red blood cells, requiring gender‑partitioned reference values. 1, 2

Clinical Chemistry Thresholds

• A restrictive transfusion threshold of hemoglobin < 70 g/L is appropriate for most stable, non‑bleeding children, including those with limited oxygen delivery (e.g., septic shock, traumatic brain injury, post‑cardiac surgery). 3
• Administering 10 mL/kg of packed red blood cells raises hemoglobin by roughly 20 g/L in pediatric patients. 3

Common Pitfalls and Error Prevention

• The most frequent laboratory error is the use of adult reference ranges or published ranges derived from different analyzer/reagent systems, leading to systematic misdiagnosis. 1, 2, 5, 3
• Reagent‑specific effects can invert age‑related APTT trends: the PTT‑A reagent shows decreasing APTT values with age, whereas the Cephascreen reagent shows increasing values across the same age span. 2, 4
• Misdiagnosis due to inappropriate reference ranges can trigger unnecessary repeat testing, mixing studies, factor assays, surgery cancellations, additional specialist consultations, and long‑term psychological impact on families. 2, 4
• When a laboratory lacks validated pediatric reference intervals for its specific analyzer/reagent, samples should be referred to a specialized pediatric laboratory that maintains population‑, reagent‑, and analyzer‑specific ranges. 1, 2, 5

Premature and Very Low‑Birth‑Weight Infants

• Validated reference values for hemostatic proteins and assays in premature neonates, especially very low‑birth‑weight infants, are urgently needed to support modern neonatal care. 1, 5
• Structured, age‑related research is required to establish comprehensive reference values for all hemostatic proteins in this vulnerable population. 1, 5, 6
• New devices and techniques for assessing hemostasis must undergo age‑specific validation studies before clinical implementation in premature infants. 1, 5, 6

Impact of Inappropriate Reference Ranges and Analyzer Specificity on Pediatric Reticulocyte Testing

Reference Range Misapplication

• Applying adult reticulocyte reference ranges—or ranges derived from different analyzer/reagent systems—to pediatric patients is the most frequent source of error and leads to systematic misdiagnosis of abnormal reticulocyte results in children. [7][8]

Analyzer and Reagent Specificity

• Reticulocyte parameters are highly dependent on the specific hematology analyzer and reagent used; reference intervals established on one platform cannot be reliably applied to results generated by a different platform. 7

Consequences of Mismatched Reference Data

• Use of non‑pediatric, non‑compatible reference ranges introduces systematic bias that can trigger unnecessary repeat testing, additional factor assays, cancellation of planned surgeries, and long‑term psychological stress for families due to misdiagnosis. [7][8]